February 28, 2022 11:45 AM EST
Pharma
Manufacturing

Emer­gen­t's trou­bled Bal­ti­more site gets $100M up­grade

Josh Sullivan

The US drug man­u­fac­tur­ing site most ar­guably in need of an up­grade is now get­ting one.

Emer­gent BioSo­lu­tions had al­ready sched­uled some main­te­nance at the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

SEC probe of Il­lu­mi­na’s Grail deal tar­gets sales fore­casts, sources say

Bris­tol My­ers touts LAG-3 strat­e­gy in lung can­cer as it preps for show­down with Mer­ck’s Keytru­da

Ar­bor Biotech­nolo­gies cuts ear­ly-stage dis­cov­ery work, lays off staff

House pass­es Biose­cure Act, send­ing Chi­nese biotech ban to Sen­ate

Pfiz­er tees up Phase 3 test in weight man­age­ment — but in an un­ex­pect­ed area

FDA ap­proves sub­cu­ta­neous Ocre­vus, broad­en­ing ac­cess to Roche and Genen­tech block­buster

A service from the Financial Times